Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Lam Research Corp Stock Research

LRCX

613.92USD+7.92(+1.31%)Market Closed
Watchlist

Market Summary

USD613.92+7.92
Market Closed
1.31%

LRCX Alerts

LRCX Stock Price

LRCX RSI Chart

LRCX Valuation

Market Cap

81.8B

Price/Earnings (Trailing)

18.14

Price/Sales (Trailing)

4.7

EV/EBITDA

14.49

Price/Free Cashflow

15.8

LRCX Price/Sales (Trailing)

LRCX Profitability

EBT Margin

29.72%

Return on Equity

58.49%

Return on Assets

25.55%

Free Cashflow Yield

6.33%

LRCX Fundamentals

LRCX Revenue

Revenue (TTM)

17.4B

Revenue Y/Y

-30.81%

Revenue Q/Q

-17.12%

LRCX Earnings

Earnings (TTM)

4.5B

Earnings Y/Y

-33.62%

Earnings Q/Q

-1.41%

Price Action

52 Week Range

299.59726.53
(Low)(High)

Last 7 days

-0.8%

Last 30 days

-7.9%

Last 90 days

-4.1%

Trailing 12 Months

63.0%

LRCX Financial Health

Current Ratio

3.09

Debt/Equity

0.59

Debt/Cashflow

0.9

LRCX Investor Care

Dividend Yield

1.12%

Dividend/Share (TTM)

6.9

Buy Backs (1Y)

2.69%

Diluted EPS (TTM)

33.21

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for LRCX

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-07
Bettinger Douglas R
sold
-1,336,900
705
-1,894
chief financial officer & evp
2023-08-03
Bettinger Douglas R
gifted
-
-
-174
chief financial officer & evp
2023-08-01
Corrreia Christina
sold
-1,153,300
708
-1,627
cvp , chief accounting officer
2023-08-01
Vahedi Vahid
sold
-9,869,440
717
-13,756
senior vice president
2023-08-01
Vahedi Vahid
acquired
2,818,600
204
13,756
senior vice president
2023-07-03
TALWALKAR ABHIJIT Y
sold
-567,002
642
-882
-
2023-04-03
TALWALKAR ABHIJIT Y
sold
-461,723
524
-881
-
2023-03-03
Hahn Ava
sold
-1,567,480
488
-3,206
chief legal officer & svp
2023-03-02
Vahedi Vahid
sold (taxes)
-1,183,300
489
-2,415
senior vice president
2023-03-02
Corrreia Christina
sold (taxes)
-209,711
489
-428
cvp , chief accounting officer

1–10 of 50

Which funds bought or sold LRCX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-26
M Holdings Securities, Inc.
sold off
-100
-260,000
-
-%
2023-09-26
BROOKFIELD Corp /ON/
sold off
-100
-323,373
-
-%
2023-09-21
Baystate Wealth Management LLC
reduced
-59.52
-11,092
11,393
-%
2023-09-21
Jefferies Group LLC
new
-
411,750
411,750
-%
2023-09-20
BARCLAYS PLC
added
174
356,558,000
509,787,000
0.32%
2023-09-13
CGC Financial Services, LLC
new
-
6,531
6,531
-%
2023-09-12
Farther Finance Advisors, LLC
added
13.58
60,507
220,603
0.05%
2023-09-07
ST GERMAIN D J CO INC
new
-
47,572
47,572
-%
2023-09-07
JAG CAPITAL MANAGEMENT, LLC
added
2.25
198,275
1,024,160
0.12%
2023-09-05
Delos Wealth Advisors, LLC
unchanged
-
112
643
-%

1–10 of 45

Latest Funds Activity

Are funds buying LRCX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own LRCX
No. of Funds

Schedule 13G FIlings of Lam Research

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
8.64%
11,788,267
SC 13G/A
Feb 03, 2023
blackrock inc.
8.1%
11,026,970
SC 13G/A
Feb 10, 2022
vanguard group inc
8.17%
11,504,998
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G/A
Feb 01, 2022
blackrock inc.
7.9%
11,100,869
SC 13G/A
Feb 12, 2021
ameriprise financial inc
3.67%
5,285,039
SC 13G/A
Feb 10, 2021
vanguard group inc
8.08%
11,640,096
SC 13G/A
Feb 08, 2021
fmr llc
-
0
SC 13G/A
Jan 29, 2021
blackrock inc.
7.8%
11,293,118
SC 13G/A
Feb 14, 2020
ameriprise financial inc
5.46%
7,927,471
SC 13G/A

Recent SEC filings of Lam Research

View All Filings
Date Filed Form Type Document
Sep 27, 2023
DEFA14A
DEFA14A
Sep 27, 2023
DEF 14A
DEF 14A
Sep 27, 2023
ARS
ARS
Aug 25, 2023
3
Insider Trading
Aug 24, 2023
8-K
Current Report
Aug 15, 2023
10-K
Annual Report
Aug 08, 2023
4
Insider Trading
Aug 07, 2023
144
Notice of Insider Sale Intent
Aug 02, 2023
4
Insider Trading
Aug 02, 2023
4
Insider Trading

LRCX Fair Value

Loading...

Peers (Alternatives to Lam Research)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
1.1T
32.7B
-9.32% 242.21%
101.72
32.14
9.90% 33.38%
158.3B
21.9B
-4.42% 46.00%
-6.3K
7.24
1.39% -100.80%
144.7B
54.0B
2.94% 32.04%
-156.98
2.68
-26.36% -104.83%
81.8B
17.4B
-7.86% 62.97%
18.14
4.7
1.17% -2.05%
60.9B
10.5B
-8.41% 44.98%
17.99
5.81
13.94% 1.97%
16.9B
3.0B
-10.27% 19.88%
108.32
5.67
20.63% -17.29%
MID-CAP
6.2B
897.4M
10.71% 92.45%
35.73
6.9
-2.87% -7.81%
5.6B
3.8B
-12.65% -0.21%
-3.19
1.46
27.35% -415.50%
5.2B
1.0B
-8.46% 164.49%
25.08
5.06
26.77% 38.56%
SMALL-CAP
1.5B
640.9M
-2.08% 44.76%
22.85
2.4
2.76% 67.69%
1.1B
461.1M
15.16% 40.51%
15.8
2.29
49.35% 107.59%
103.0M
117.9M
-14.49% -18.39%
28.5
0.87
19.93% -73.89%
46.4M
29.1M
-6.29% 50.55%
101.01
1.59
49.22% -84.40%

Lam Research News

Investor's Business Daily
Dow Jones Futures Rise After Market Rallies Off Lows; Tesla Falls ....
Investor's Business Daily,
2 hours ago
The Motley Fool
Is Lam Research Stock a Buy Now?.
The Motley Fool,
41 hours ago

Returns for LRCX

Cumulative Returns on LRCX

29.8%


10-Year Cumulative Returns

32.7%


7-Year Cumulative Returns

33.9%


5-Year Cumulative Returns

23.9%


3-Year Cumulative Returns

Risks for LRCX

What is the probability of a big loss on LRCX?

78.1%


Probability that Lam Research stock will be more than 20% underwater in next one year

63.9%


Probability that Lam Research stock will be more than 30% underwater in next one year.

41.9%


Probability that Lam Research stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does LRCX drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Lam Research was unfortunately bought at previous high price.

Drawdowns

Financials for Lam Research

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue-7.6%17,42918,85719,04817,99717,22716,73716,52415,75414,62613,27311,92911,05610,0459,6149,5499,4899,65410,41810,87110,93011,077
Gross Profit-7.6%7,7778,4198,6308,2327,8727,6867,6507,2766,8056,1705,5575,1334,6094,4094,3174,2824,3584,7575,0135,0745,165
Operating Expenses-0.7%2,6022,6202,5812,5242,4902,4682,4282,3832,3232,2492,1372,0361,9351,8741,9101,8721,8941,9541,9491,9621,952
  S&GA Expenses-1.2%833843867869886893880862830798759715682665690685702731738756762
  R&D Expenses-0.5%1,7271,7361,7141,6551,6041,5751,5491,5201,4931,4501,3771,3211,2521,2091,2201,1861,1911,2231,2101,2061,190
EBITDA-100.0%-5,9456,1345,8345,7025,6545,6815,3054,8834,3133,7613,4343,0202,8712,829------
EBITDA Margin-100.0%-0.32*0.32*0.32*0.33*0.34*0.34*0.34*0.33*0.32*0.32*0.31*0.30*0.30*0.30*------
Interest Expenses-175---176---204---172---77.00---84.00
Earnings Before Taxes-8.8%5,1095,6055,8005,5045,1935,1435,1684,7924,3713,8103,2802,9732,5752,4362,3932,3802,4472,7952,9813,0553,152
EBT Margin-100.0%-0.30*0.30*0.31*0.30*0.31*0.31*0.30*0.30*0.29*0.27*0.27*0.26*0.25*0.25*------
Net Income-8.3%4,5114,9175,1254,8514,6054,5414,5904,2653,9083,4602,9642,6092,2522,0972,0702,1242,1912,6712,9022,3232,381
Net Income Margin-100.0%-0.26*0.27*0.27*0.27*0.27*0.28*0.27*0.27*0.26*0.25*0.24*0.22*0.22*0.22*------
Free Cashflow-100.0%-4,5003,5313,8323,1004,0924,4993,4033,5882,9652,3422,3052,1262,1942,585------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-2.4%18,78219,24319,20618,72117,19616,58916,68515,56615,89215,28515,37015,05714,55912,93911,91412,34412,00112,89510,76810,95812,492
  Current Assets-3.7%13,22813,73013,70913,61312,28511,88812,10311,14511,65211,32211,46811,27510,8549,4098,4558,8358,5609,4427,3567,5169,150
    Cash Equivalents0.6%5,3375,3064,4854,2563,5224,1955,0874,0424,4183,6733,6874,1295,1693,9623,0364,6073,9134,9323,3602,5684,769
  Inventory-1.3%4,8164,8824,8204,3603,9663,4793,0742,8722,6892,5522,3492,1381,9001,6751,5291,4831,5401,6221,7031,8741,876
  Net PPE----------------1,0301,0591,0401,013951903
  Goodwill-1.4%1,6001,6221,6001,5001,5001,5141,4901,4901,4901,5001,5001,5001,5001,4841,5001,5001,4851,4851,4851,4851,485
Liabilities-2.4%10,57110,83610,90211,30910,91710,56310,2109,7469,8659,9109,8629,6329,3768,3897,4967,3657,2787,5544,9275,5765,899
  Current Liabilities-5.8%4,1854,4414,5475,0534,5654,1953,8633,4093,5283,6123,5913,4073,1622,1062,5662,4582,3722,8062,1672,8253,150
  Long Term Debt0.1%5,0034,9974,9964,9964,9985,0014,9884,9894,9904,9924,9924,9934,9715,0443,7863,7883,8233,8021,8131,8051,807
Shareholder's Equity-2.3%8,2108,4078,3057,4136,2786,0266,4765,8206,0275,3725,5035,4195,1724,5384,3794,9364,6745,2915,7845,3236,502
  Retained Earnings2.7%22,03221,46020,87919,64518,45517,45116,63815,65314,68513,72612,84012,15711,52110,99110,58410,2339,9319,5489,1658,7688,261
  Additional Paid-In Capital1.7%7,8097,6807,6067,4937,4157,2897,2207,1127,0536,9226,8556,7626,6966,5786,5296,4566,4096,3156,2576,1956,144
Shares Outstanding-1.0%133135135136137139141142143143144145145145144145144151155156157
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations15.1%5,1794,5003,5313,8323,1004,0924,4993,4033,5882,9652,3422,3052,1262,1942,5852,9203,1763,0143,1312,5182,656
  Share Based Compensation-0.4%287288282272259246233222220217209202189181187180187190177181172
Cashflow From Investing3.7%-534-555-565-1126121,3771,5881,47273.00-1,046-992-1,796-244-437-1,615-214-1,6372473,3422,3802,749
Cashflow From Financing-0.5%-2,830-2,816-3,546-3,462-4,578-4,937-4,675-4,963-4,166-2,221-707-993-623-2,715-1,297-661-2,390-3,022-4,852-4,733-3,272
  Dividend Payments2.7%908884860835815793769745727709686665657654662663678595504409308
  Buy Backs-0.3%2,0172,0242,7802,7393,8663,4213,1773,4862,6982,3071,4581,7401,3702,4373,1262,1233,7813,9783,1244,2342,653

LRCX Income Statement

2023-06-25
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jun. 25, 2023
Jun. 26, 2022
Jun. 27, 2021
Income Statement [Abstract]   
Revenue$ 17,428,516$ 17,227,039$ 14,626,150
Cost of goods sold9,573,4259,355,2327,820,844
Restructuring charges, net - cost of goods sold78,16600
Total cost of goods sold9,651,5919,355,2327,820,844
Gross margin7,776,9257,871,8076,805,306
Research and development1,727,1621,604,2481,493,408
Selling, general, and administrative832,753885,737829,875
Restructuring charges, net - operating expenses42,15000
Total operating expenses2,602,0652,489,9852,323,283
Operating income5,174,8605,381,8224,482,023
Other income (expense), net(65,650)(188,708)(111,219)
Income before income taxes5,109,2105,193,1144,370,804
Income tax expense(598,279)(587,828)(462,346)
Net income$ 4,510,931$ 4,605,286$ 3,908,458
Net income per share:   
Basic (usd per share)$ 33.30$ 32.92$ 27.22
Diluted (usd per share)$ 33.21$ 32.75$ 26.90
Number of shares used in per share calculations:   
Basic (in shares)135,472139,899143,609
Diluted (in shares)135,834140,628145,320

LRCX Balance Sheet

2023-06-25
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 25, 2023
Jun. 26, 2022
ASSETS:  
Cash and cash equivalents$ 5,337,056$ 3,522,001
Investments37,641135,731
Accounts receivable, less allowance of $5,344 as of June 25, 2023 and $5,606 as of June 26, 20222,823,3764,313,818
Inventories4,816,1903,966,294
Prepaid expenses and other current assets214,149347,391
Total current assets13,228,41212,285,235
Property and equipment, net1,856,6721,647,587
Restricted cash and investments250,316251,534
Goodwill1,622,4891,515,113
Intangible assets, net168,454101,850
Other assets1,655,3001,394,313
Total assets18,781,64317,195,632
LIABILITIES AND STOCKHOLDERS’ EQUITY:  
Trade accounts payable470,7021,011,208
Accrued expenses and other current liabilities2,010,6371,974,272
Deferred profit1,695,2211,571,898
Current portion of long-term debt and finance lease obligations8,3587,381
Total current liabilities4,184,9184,564,759
Long-term debt and finance lease obligations, less current portion5,003,1834,998,449
Income taxes payable882,084931,117
Other long-term liabilities501,286422,941
Total liabilities10,571,47110,917,266
Commitments and contingencies
Stockholders’ equity:  
Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding00
Common stock, at par value of $0.001 per share; authorized 400,000 shares as of June 25, 2023 and June 26, 2022; issued and outstanding 133,297 shares as of June 25, 2023, and 136,975 shares as of June 26, 2022133137
Additional paid-in capital7,809,0027,414,916
Treasury stock, at cost, 161,380 shares as of June 25, 2023, and 157,087 shares as of June 26, 2022(21,530,353)(19,481,429)
Accumulated other comprehensive loss(100,706)(109,982)
Retained earnings22,032,09618,454,724
Total stockholders’ equity8,210,1726,278,366
Total liabilities and stockholders’ equity$ 18,781,643$ 17,195,632
Timothy M. Archer
14100
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.